Agenda
07:45 – 09:15
Registration, Coffee and Networking
09:15 – 09:25
Chair’s Introduction
John Prendergast – Principal Decontamination Engineer – NHS Wales Shared Services Partnership (Confirmed)
09:25 – 09:50
Biofilm Risk for Flexible Endoscope Decontamination
The current process assurance tests for endoscope decontamination. What is Biofilm and the potential of Biofilm accumulation and associated challenges that could pose. Discuss whether Flexible endoscopes should be categorised by risk factor with additional process steps
Rob Warburton – Trust Decontamination Lead – Manchester University NHS Foundation Trust (Confirmed)
09:50 – 10:15
The Seven Deadly Sins of Endoscope Decontamination
A look at the risks and challenges we face reprocessing re-usable flexible endoscopes within healthcare. Should we accept disinfection or should we be migrating to sterilization of endoscopes? Where are the risks and are we doing all we can to ensure a safe endoscope for the next patient?
John Prendergast – Principal Decontamination Engineer – NHS Wales Shared Services Partnership (Confirmed)
10:15 – 10:40
Leadership, Visibility and Retention – Supporting Retention and Performance through Role Specific Training
Endoscopy decontamination work is habitually undertaken on or near the unit by a bespoke team. This differs significantly from many services which use the generic Sterile Services department. This is indicative of the specialised demands placed upon our decontamination colleagues. Despite this, there has traditionally been very little in terms of role specific training external to the local training provided to new starters at individual Trusts. This is in harsh contrast to the training opportunities offered to nursing and medical staffing and has a correspondingly detrimental impact upon retention rates.
The North West Endoscopy Academy is implementing bespoke courses to support colleagues to build rewarding careers within endoscopy and provide some consistency of message in the training provided across the region. In this presentation we will look at the model applied to the other under-provided-for endoscopic staff group – Admin and Clerical colleagues – and the benefits in terms of retention and performance that role specific training has yielded. We will look at how this model can be applied to the decontamination staff group and the challenges faced in adapting this model to same. Finally, we will discuss the plans for the upcoming decontamination training programme we are offering and encourage engagement therein through releasing staff to attend and\or supporting courses as subject matter experts.
Michael Dawson – North West Endoscopy Academy GM Spoke Centre Manager – Manchester University NHS Foundation Trust (Confirmed)
10:40 – 11:00
Questions and Answers
11:00 – 11:30
Morning Coffee and Networking
11:30 – 12:00
Protein Residue Removal Research Project
This will a brief overview of the work done in Cardiff and Vale University Health Board to combat residual proteins on processed reusable medical devices since the re-write of WHTM 01-01 Part A / HTM 01-01 Part A. The presentation will cover risks associated with residual proteins, optimisation of the medical device decontamination life cycle and quantifiable data to prove results.
Mark Campbell – Head of Decontamination – Cardiff and Vale University Health Board (Confirmed)
12:00 – 12:40
Innovative Surgical Instruments Pre-Treatment with Bircarmed Technology
12:40 – 12:50
Questions and Answers
12:50 – 13:50
Afternoon Lunch and Networking
13:50 – 14:30
Transforming Endoscopy Decontamination
Exploring the innovative technologies that could completely transform your service, the efficiency you could achieve along with the financial savings available. What are the barriers holding this back and how can the community overcome them for a sustainable future.
14:30 – 14:50
Net Zero in Sterile Services
14:50 – 15:10
Medical Device Management: Ensuring Safe and Efficient Delivery to Reduce Impact Upon Patient Care
Due to ever increasing figures of individuals waiting for treatment in the NHS, the building and roll out of surgical hubs is being scaled up across the country to ease pressure on elective surgery. As a result, a quick turnaround of existing medical devices and challenges to procurement are posing great risks to the forecasted favourable outcomes.
Given the challenges and risk, we cannot deny that the organisation’s approach in their medical device management is a key to assist in achieving a safe and efficient delivery of service to help reduce impact on patient care and the healthcare system. But how?